Immunohistochemical analysis of the tumor tissues further corroborated the anti-proliferative effect of KTC1101, indicated by a notable reduction in Ki67 expression, and confirmed its on-target effect with decreased phosphorylation of AKT (Fig. 3L-O). The gene discussed is AKT1; the disease is neoplasm.